Results 121 to 130 of about 260,325 (267)

207:oral Revising the Zanzibar’s essential health care package

BMJ Global Health, 2022
Kjell Arne Johansson, Peter Hangoma, Omar Mwalim Omar   +2 more
doaj   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Improving Medication Management in Indonesian Aged Care Homes: Research Priority Setting With Stakeholders. [PDF]

Pharmacol Res Perspect
Sari YM, Bell JS, Adhi S, Alhamid U, Dewiasty E, Dhanira A, Kusharto CM, Novriany ED, Notario D, Pambudi I, Situmeang R, Soenarti S, Widodo MR, Wangge G.   +13 more
europepmc   +1 more source

81:oral Equity for all? A policy analysis of priority to refugees and asylum seekers’ sexual and reproductive health in Norway (2010–2019)

BMJ Global Health, 2022
KH Onarheim, MES Haaland
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Translating Sustainable Development Goals into Veterinary Action: A Structured Priority-Setting Framework. [PDF]

Vet Sci
Yonar H, Beşoluk FÇ, Yonar A, Tekin ME, Beşoluk K.   +4 more
europepmc   +1 more source

131:oral Where should we draw the line?’ A qualitative study of ethical dilemmas amongst nursing home doctors during the first half of the COVID-19 pandemic

BMJ Global Health, 2022
Kristine Husøy Onarheim, Ingrid Miljeteig, Emily McLean   +2 more
doaj   +1 more source

Setting research priorities in anaesthesia [PDF]

British Journal of Anaesthesia, 2012
R P, Mahajan, C S, Reilly
openaire   +2 more sources

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Beyond Research Priorities: Stakeholder-Identified Health System Challenges From an Australian Childhood Cancer Priority-Setting Partnership. [PDF]

Health Expect
De Silva G, Robertson EG, Bowers A, Pole JD, Patel SK, Cummings J, Bradford N.   +6 more
europepmc   +1 more source